【摘要】 目的:研究清肠解毒方与化疗联合治疗晚期结直肠癌(CRC)患者(湿热内蕴型)的临床疗效及对预后的影响。方法:选取晚期CRC患者(湿热内蕴型)67例，分成对照组(n=32)与治疗组(n=35);对照组采用常规化疗方案，治疗组采用清肠解毒方联合化疗方案；观察比较两组患者的治疗疗效、肿瘤标志物表达水平、血清因子水平及预后，并统计治疗期间不良反应发生情况。结果:两组总有效率比较差异无统计学意义(P>0.05)。治疗后两组癌胚抗原(CEA)、糖类抗原125(CA125)、糖类抗原(CA199)表达水平均有所下降，且治疗组下降更明显(P<0.05)。治疗后，两组WBC、PLT、NEUT均有明显降低，与对照组相比，治疗组WBC、PLT下降更少，NEUT下降更多(P<0.05)。随访截至2024年1月，治疗组、对照组中位随访时间为27.3、28.5个月，治疗组OS、PFS均明显高于对照组(P<0.05)。治疗组消化道不良反应、肝肾功能损伤、神经系统毒性发生率更低(P<0.05)。结论:清肠解毒方联合化疗能有效改善晚期CRC患者肿瘤标志物表达水平与血清因子水平，延长OS、PFS,且安全性好，是值得进一步研究应用的治疗方案。更多还原

【Abstract】 Objective:To observe the clinical effect and prognosis of Qingchang Jiedu formula combined with chemotherapy in the treatment of patients with advanced colorectal cancer(CRC)(internal dampness-heat accumulation syndrome type).Methods:A total of 67 patients with advanced CRC(internal dampness-heat accumulation syndrome type) who underwent chemotherapy were divided into the control group(n=32) and the traditional Chinese medicine group(n=35),the control group were treated with conventional chemotherapy, the traditional Chinese medicine group were treated with self-made Qingchang Jiedu formula combined with chemotherapy.Therapeutic effects, expression levels of tumor markers, serum factor level, and prognosis were observed compared and the incidence of adverse reactions during treatment were statistically analyzed.Results:The total effective rate between the two groups was no significant difference(P>0.05).After treatment, the expression levels of carcinoembryonic antigen(CEA),carbohydrate antigen 125(CA125) and carbohydrate antigen 199(CA199) in both groups decreased, and the levels of traditional Chinese medicine group decreased significantly(P<0.05).After treatment, both groups showed significant reductions in WBC,PLT,and NEUT.Compared with the control group, the traditional Chinese medicine group showed less decrease in WBC and PLT,and more decrease in NEUT(P<0.05).As of January 2024,the median follow-up time of the traditional Chinese medicine group and the control group was 27.3 months and 28.5 months, respectively.OS and PFS of the traditional Chinese medicine group were significantly longer than those of the control group(P<0.05).The incidence rates of gastrointestinal adverse reactions, liver and kidney function damage, and neurological toxicity in the traditional Chinese medicine group were significantly lower(P<0.05).Conclusion:Qingchang Jiedu formula combined with chemotherapy can effectively improve the expression levels of tumor markers and serum factor level, and prolong OS and PFS of patients with advanced CRC,with good safety.更多还原